000178922 001__ 178922
000178922 005__ 20240229143600.0
000178922 0247_ $$2doi$$a10.1136/bmjopen-2021-054091
000178922 0247_ $$2pmid$$apmid:35197344
000178922 037__ $$aDKFZ-2022-00349
000178922 041__ $$aEnglish
000178922 082__ $$a610
000178922 1001_ $$aMaurer, Tabea$$b0
000178922 245__ $$aRandomised controlled trial testing the feasibility of an exercise and nutrition intervention for patients with ovarian cancer during and after first-line chemotherapy (BENITA-study).
000178922 260__ $$aLondon$$bBMJ Publishing Group$$c2022
000178922 3367_ $$2DRIVER$$aarticle
000178922 3367_ $$2DataCite$$aOutput Types/Journal article
000178922 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1646049116_2946
000178922 3367_ $$2BibTeX$$aARTICLE
000178922 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000178922 3367_ $$00$$2EndNote$$aJournal Article
000178922 500__ $$a#LA:C020#
000178922 520__ $$aAdvanced ovarian cancer is a severe disease with major side effects caused by peritoneal carcinomatosis, ascites and gastrointestinal involvement as well as exhaustive treatment like debulking surgery and combination chemotherapy. Two most frequently reported side effects are muscle wasting and malnutrition, leading to frailty, decreased health-related quality of life (HRQoL) and cancer-related fatigue (CRF). As muscle wasting and malnutrition often commence during first-line chemotherapy and develop progressively into a refractory state, an early intervention is warranted. This pilot study aimed to evaluate the safety and acceptance of a combined exercise and nutrition intervention during and after first-line chemotherapy.The pilot study was conducted as a monocentric 1:1 randomised controlled trial (RCT) with an intervention group (IG) and a control group (CG). Participants were divided by chance into IG or CG. Information on group allocation was conveyed to the study coordinator responsible for making an appointment with the patients for the baseline assessment as well as the physiotherapist and nutritionist responsible for the intervention and outcome assessment in both groups.Eligibility criteria included women ≥18 years of age, diagnosed with ovarian cancer, tubal cancer or peritoneal cancer and primary or interval debulking, scheduled but not started adjuvant or neoadjuvant chemotherapy and sufficient German-language skills.The IG received a 12-month exercise and nutrition programme, the CG continued to follow usual care.Primary outcomes were recruitment rate, adherence to intervention, completion rate and adverse events. In addition, in-person assessments (eg, HRQoL, CRF, muscle quality and function and dietary intake and quality) were conducted at baseline (T0, before chemotherapy), week 9 (T1, mid-chemotherapy), week 19 (T2, after completion of chemotherapy) and after 12 months of intervention (T3).Of 60 eligible patients, 15 patients signed informed consent (recruitment rate=25.0%) and were randomised into IG (n=8) and CG (n=7). Eleven participants completed the study (completion rate, 73.3%), one patient dropped out due to loss of interest, one due to poor health, one was lost to follow-up and one patient died.The BENITA (Bewegungs- und Ernährungsintervention bei Ovarialkrebs) study demonstrated the safety and acceptance of an exercise and nutrition intervention integrated into first-line therapy and follow-up care of ovarian cancer. A large multicentre RCT is planned to investigate the effectiveness of the intervention on HRQoL, CRF and survival and to establish means of implementation into oncology guidelines and clinic routine.DRKS00013231.
000178922 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000178922 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000178922 650_7 $$2Other$$aadult oncology
000178922 650_7 $$2Other$$aepidemiology
000178922 650_7 $$2Other$$agynaecological oncology
000178922 7001_ $$00000-0003-2141-2162$$aBelau, Matthias Hans$$b1
000178922 7001_ $$avon Grundherr, Julia$$b2
000178922 7001_ $$aSchlemmer, Zoe$$b3
000178922 7001_ $$aPatra, Stefan$$b4
000178922 7001_ $$00000-0002-8808-6667$$aBecher, Heiko$$b5
000178922 7001_ $$aSchulz, Karl-Heinz$$b6
000178922 7001_ $$aZyriax, Birgit-Christiane$$b7
000178922 7001_ $$aSchmalfeldt, Barbara$$b8
000178922 7001_ $$0P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253$$aChang-Claude, Jenny$$b9$$eLast author$$udkfz
000178922 773__ $$0PERI:(DE-600)2599832-8$$a10.1136/bmjopen-2021-054091$$gVol. 12, no. 2, p. e054091 -$$n2$$pe054091$$tBMJ open$$v12$$x2044-6055$$y2022
000178922 909CO $$ooai:inrepo02.dkfz.de:178922$$pVDB
000178922 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000178922 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000178922 9141_ $$y2022
000178922 915__ $$0LIC:(DE-HGF)CCBYNCNV$$2V:(DE-HGF)$$aCreative Commons Attribution-NonCommercial CC BY-NC (No Version)$$bDOAJ
000178922 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBMJ OPEN : 2021$$d2022-11-12
000178922 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-12
000178922 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-12
000178922 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-01-14T19:11:08Z
000178922 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-01-14T19:11:08Z
000178922 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Open peer review$$d2021-01-14T19:11:08Z
000178922 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-12
000178922 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-12
000178922 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-12
000178922 9202_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000178922 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000178922 980__ $$ajournal
000178922 980__ $$aVDB
000178922 980__ $$aI:(DE-He78)C020-20160331
000178922 980__ $$aUNRESTRICTED